Pfizer nurtures talent for China R&D hubs

Even as it whittles down research operations in the U.S. and Europe, Pfizer ($PFE) is laying the groundwork for a new generation of Chinese scientists to advance its R&D. In another piece on Western drugmakers' research drives in the country, China Daily covers Pfizer pro Tan Lingshi's work to recruit Chinese scientists for his employer's growing research operations in the rising superpower....